R 1599
Alternative Names: R1599Latest Information Update: 16 Jul 2016
At a glance
- Originator Roche
- Class
- Mechanism of Action Interleukin 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Osteoarthritis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Osteoarthritis in Unknown